Market of Monoclonal Antibodies for Oncology to Flourish by 2013
With the increasing number of cancer patients and rising health insurance coverage, the global monoclonal antibodies market for oncology will witness a significant growth during 2010-2013, says RNCOS in its latest research study.
- (1888PressRelease) October 19, 2010 - As per our new research report, "Global Protein Therapeutics Market Analysis" the global monoclonal antibodies market is expected to witness stupendous growth rate in the coming years. Our study indicates that the usage of monoclonal antibody for the treatment of cancer has recorded explosive growth in recent years. In fact, oncology was the most dominant therapeutic area for marketed monoclonal antibodies with around 42% of the total monoclonal antibody revenue coming from the sales of antibodies for cancer treatment in 2009.
We have identified some critical factors acting as a catalyst for the industry's current and future growth outlook. The report reveals that rising incidences of cancer coupled with growing health insurance industry will drive renewed interests of the investors in the monoclonal antibodies therapeutics market for oncology at the global level. Further, introduction of new products will lead to intense competition from already established brands in the coming years, which will further drive the market segment.
Besides, our report provides a thorough research and prudent analysis of Global protein therapeutics market. The systematic and thorough research, studies the global protein therapeutics market to give an insight into its various segments, including Monoclonal Antibodies, Erythropoietins, Insulin, Interferon, Human Growth Hormone, Blood Clotting Factor, Granulocyte Colony Stimulating Factor, and Follicle Stimulating Hormone. The comprehensive analysis of the market states monoclonal antibodies as the current highest share-holder but future will see insulin segment posting a rapid growth.
"Global Protein Therapeutics Market Analysis" provides thorough research and rational analysis along with reliable statistics of the global protein therapeutics industry. The report also provides extensive information on the traditional markets as well as on the emerging technologies. Besides, an insight of trends prevailing in the regional protein therapeutics market segments across the globe has been covered in the report. Analysis and statistics regarding market size, growth, share, segmentation, and geographic distribution have been thoroughly studied in the report to give a comprehensive view of the global protein therapeutics market. The report has thoroughly examined current market trends; industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years.
For FREE SAMPLE of this report visit: http://rncos.com/Report/IM557.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm
About RNCOS:
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.
###
space
space
Contact Information
- Shushmul Maheshwari
- Rncos
- B 129 Sector 6
- Noida 201301
- 201301
- Voice: 91-120-4224-700
- Visit our Site
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam